Résultats de la recherche
10
Tout
Rechercher les filtres
Mot-clé
crispr
Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Nexiguran Ziclumeran (nex-z) for the Treatment of Transthyretin (ATTR) Amyloidosis with Cardiomyopathy
26 mars 2025 07h30 HE
|
Intellia Therapeutics, Inc.
CAMBRIDGE, Mass., March 26, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based...
Global CRISPR Cas9 Market Opportunity & Clinical Trials Outlook 2024-2029: 25 Therapies Currently in Trial - Many will Penetrate the Market in the Imminent 5-7 Years
24 mars 2025 05h02 HE
|
Research and Markets
Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Global CRISPR Cas9 Market Opportunity & Clinical Trials Outlook 2029" report has been added to ResearchAndMarkets.com's offering. Antecedently,...
SNIPR Biome Strengthens IP Portfolio with Patent Granted for a Novel CRISPR-Cas System
24 févr. 2025 04h40 HE
|
SNIPR BIOME
Grant of a patent on February 26th 2025 by the European Patent Office protecting the newly-discovered and characterised CRISPR-CasS system.
Consumer Genomics Market Size to Hit USD 10.8 Billion by 2032, Growing at a 24.6% CAGR - SNS Insider
31 janv. 2025 09h50 HE
|
SNS Insider pvt ltd
Pune, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Global Consumer Genomics Market Size & Growth Analysis: “According to SNS Insider, the global Consumer Genomics Market size was valued at USD 1.5 Billion...
Genotyping Market Size is Expected to Reach USD 70.85 Billion by 2033, Growing at a CAGR of 14.32%: Straits Research
22 janv. 2025 10h20 HE
|
Straits Research Private Limited - Garner Insights
New York, United States, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Genotyping involves analyzing DNA sequences to ascertain the genetic makeup of the genotypes of living things, such as people, plants,...
CRISPR-based Gene Editing Market Report 2025, with Company Profiles of the Top 10+ Major Market Players
13 janv. 2025 11h45 HE
|
Research and Markets
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "CRISPR-based Gene Editing Market by Product & Service, by Application, by End-User, and By Region" report has been added to ...
ERS Genomics launches ‘Express License’ platform to democratise access to CRISPR/Cas9
13 janv. 2025 09h00 HE
|
ERS Genomics
ERS Genomics (‘ERS’), the CRISPR licensing company, today announces the launch of its Express License platform.
Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025
12 janv. 2025 19h05 HE
|
Caribou Biosciences, Inc.
-- CB-010 GALLOP Phase 1 trial initiated in lupus -- -- CB-012 AMpLify Phase 1 trial in r/r AML completes dose level 3 with no DLTs; enrolling patients at dose level 4 -- -- CB-010 ANTLER 2L LBCL...
Caribou Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
07 janv. 2025 16h00 HE
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced that Rachel...
Caribou Biosciences Appoints Sri Ryali as Chief Financial Officer
02 janv. 2025 08h00 HE
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the...